5-Amino-1MQ
Also known as: 5-Amino 1-Methylquinolinium · NNMT Inhibitor
A small molecule NNMT inhibitor that boosts cellular energy metabolism, promotes fat loss, and may reverse diet-induced obesity by restoring NAD+ levels.
Overview
5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that plays a central role in cellular energy metabolism. NNMT consumes methyl groups from SAM (S-adenosylmethionine) and degrades NAD+ precursors, effectively reducing the cell's energy currency. When NNMT is overexpressed — as commonly seen in obesity and metabolic dysfunction — it creates a metabolic bottleneck that promotes fat storage and reduces energy expenditure. By inhibiting NNMT, 5-Amino-1MQ restores NAD+ levels, increases SAM availability for methylation reactions, activates the sirtuin pathway, and shifts cellular metabolism toward fat oxidation.
In preclinical studies, 5-Amino-1MQ has demonstrated significant reductions in body weight and fat mass without affecting food intake, suggesting it works by increasing metabolic rate rather than suppressing appetite. Available in both injectable and oral formulations, it is increasingly popular in health optimization protocols for body composition improvement.
Mechanism of Action
Inhibits nicotinamide N-methyltransferase (NNMT), preventing the enzyme from consuming SAM and degrading NAD+ precursors. This restores intracellular NAD+ pools, activates sirtuins (SIRT1/SIRT3), enhances mitochondrial function, increases fatty acid oxidation, and shifts adipocyte metabolism from lipogenesis to lipolysis.
Key Benefits
Potential Side Effects
Common Stacks
This peptide is commonly combined with the following compounds for synergistic effects:
Known Interactions
The following interactions have been documented for 5-Amino-1MQ. Always consult a healthcare professional before combining compounds.
Synergistic (1)
5-Amino-1MQ inhibits NNMT (which degrades NAD+) while NMN provides NAD+ precursors. Together they boost cellular NAD+ levels from both sides.
Scientific References
Quick Reference
Typical Dose
0.5mg-2mg (inj) or 50mg-150mg (oral)
Frequency
1-2x daily (inj AM/PM) or 2-3x daily (oral)
Route
Subcutaneous injection or oral capsule
Half-Life
~4-6 hours
Cycle Length
8-16 weeks, followed by 4 weeks recovery
FDA Status
Research compound — not FDA approved. Currently in preclinical development.
Need to calculate dosing?
Use our reconstitution calculator to determine exact syringe measurements.
Open CalculatorThis information is for educational purposes only. Consult a qualified healthcare professional before using any peptide. Dosing information reflects commonly reported protocols and may not be appropriate for everyone.
Related Peptides in Supplements & Nutraceuticals
Alpha GPC
A highly bioavailable choline source that crosses the blood-brain barrier, supporting acetylcholine synthesis, cognitive function, and growth hormone release.
Read moreVitamin B12 (Injectable)
Injectable vitamin B12 provides superior bioavailability for energy production, methylation support, neurological function, and red blood cell formation.
Read moreCDP-Choline
A naturally occurring nootropic that provides both choline and cytidine for acetylcholine synthesis, neuroprotection, and enhanced phospholipid membrane repair.
Read more